K. Wyvill

发表

Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.

S. Steinberg, S. Pittaluga, R. Yarchoan, 2007, Blood.

Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency

E. Androphy, R. Badolato, C. Mcintosh, 2018, mSphere.

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

S. Steinberg, S. Pittaluga, D. Whitby, 2011, Blood.

Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas

M. Raffeld, D. Whitby, R. Yarchoan, 2017, Journal of the National Cancer Institute.

Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome

D. Esposito, D. Whitby, R. Bagni, 2014, PLoS pathogens.

T-cell responses to KSHV infection: a systematic approach

J. Lifson, D. Douek, C. Fennessey, 2017, Oncotarget.

Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.

S. Steinberg, R. Yarchoan, G. Tosato, 2007, Critical reviews in immunology.

A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma

S. Steinberg, W. Figg, D. Whitby, 2019, Clinical Cancer Research.

Using Quantitative Imaging Techniques to Assess Vascularity in AIDS-Related Kaposi's Sarcoma

Y. Tao, V. Chernomordik, A. Vogel, 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs

J. Goedert, T. O'Brien, R. Yarchoan, 1996 .

Viral, immunologic, and clinical features of primary effusion lymphoma.

W. Wilson, S. Steinberg, E. Jaffe, 2019, Blood.

Serum inactivation contributes to the failure of stromal‐derived factor‐1 to block HIV‐I infection in vivo

D. Davis, R. Yarchoan, G. Tosato, 2003, Journal of leukocyte biology.

An IL 6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus

S. Steinberg, S. Chanock, J. Metcalf, 2000 .

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

S. Steinberg, M. Bevans, W. Figg, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

R. Yarchoan, G. Tosato, R. Little, 2001, Blood.

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma

S. Steinberg, D. Venzon, M. Rudek, 2017, The oncologist.

An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

S. Steinberg, S. Pittaluga, D. Whitby, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

S. Steinberg, S. Pittaluga, D. Whitby, 2014, Blood.

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

S. Steinberg, S. Pittaluga, D. Whitby, 2013, Blood.

Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

S. Steinberg, E. Jaffe, S. Pittaluga, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lack of Detection of Xenotropic Murine Leukemia Virus-Related Virus in HIV-1 Lymphoma Patients

V. Pathak, Chawaree Chaipan, K. Delviks-Frankenberry, 2011, Advances in virology.

Pharmacokinetics of 2',3' ‐dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications

S. Broder, R. Yarchoan, K. Wyvill, 1991, Clinical pharmacology and therapeutics.

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.

L. Kostrikis, A. Hatzakis, G. Pavlakis, 2002, Nature Reviews Immunology.

Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men.

S. Steinberg, S. Chanock, J. Metcalf, 2000, Blood.

Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.

S. Steinberg, R. Yarchoan, G. Tosato, 2006, Blood.

Initial Clinical Experience with Dideoxynucleosides as Single Agents and in Combination Therapy

H. Mitsuya, S. Broder, C. Perno, 1990, Annals of the New York Academy of Sciences.

18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

S. Steinberg, M. Whatley, D. Whitby, 2015, The Journal of infectious diseases.

Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma

Laleh Najafizadeh, Amir H. Gandjbakhche, Jana M. Kainerstorfer, 2013, PloS one.

interleukin-12 for AIDS-related Kaposi's sarcoma Phase II study of pegylated liposomal doxorubicin in combination with

S. Steinberg, S. Pittaluga, V. Wang, 2013 .

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

R. Leighty, D. Whitby, R. Yarchoan, 2012, The Journal of infectious diseases.

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.

M. Iadarola, J. Kovacs, P. Burbelo, 2010, The Journal of infectious diseases.

Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Interleukin-12 for AIDS-Related Kaposi’s Sarcoma Running head: IL-12 AND LIPOSOMAL DOXORUBICIN FOR KAPOSI’S SARCOMA

S. Steinberg, S. Pittaluga, R. Yarchoan, 2007 .

Quantitative Assessment of Tumor Vasculature and Response to Therapy in Kaposi's Sarcoma Using Functional Noninvasive Imaging

A H Gandjbakhche, A. Vogel, A. Gandjbakhche, 2004, Technology in cancer research & treatment.

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.

S. Steinberg, S. Chanock, J. Metcalf, 2000, Blood.

Variant genotypes of FcγRIIIA influence the development of Kaposi's sarcoma in HIV-infected men

S. Steinberg, S. Chanock, J. Metcalf, 2000 .

Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.

J. Goedert, T. O'Brien, J. Goedert, 1996, Blood.

A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses.

J. Zeldis, C. Peer, R. Yarchoan, 2014, Journal of pharmaceutical and biomedical analysis.

Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy

S. Steinberg, S. Pittaluga, D. Whitby, 2014 .

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

L. Kostrikis, A. Hatzakis, G. Pavlakis, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

S. Steinberg, S. Pittaluga, D. Whitby, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Pharmacokinetics of TNP‐470, a New Angiogenesis Inhibitor

E. Reed, R. Lush, R. Yarchoan, 1997, Pharmacotherapy.

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV

S. Steinberg, M. Raffeld, S. Pittaluga, 2012, Infectious Agents and Cancer.

[18F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters

S. Steinberg, M. Whatley, D. Whitby, 2012, Infectious Agents and Cancer.

CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.

A. Tsiatis, S. Steinberg, D. Venzon, 1991, Annals of internal medicine.

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

H. Mitsuya, S. Broder, R. Yarchoan, 1990, The Lancet.

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV

S. Steinberg, M. Raffeld, S. Pittaluga, 2012, Infectious Agents and Cancer.

Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration

R. Ramaswami, I. Sereti, Amrit P. Singh, 2023, AIDS.

Safety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection.

S. Steinberg, D. Whitby, R. Ramaswami, 2021, Clinical Cancer Research.

F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus– Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters

S. Steinberg, M. Whatley, D. Whitby, 2015 .

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

W. Wilson, S. Steinberg, S. Broder, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of thalidomide in AIDS-related Kaposi's sarcoma.

S. Steinberg, J. Goedert, W. Figg, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

S. Steinberg, S. Pittaluga, D. Whitby, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

S. Steinberg, S. Pittaluga, D. Whitby, 2011 .

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.

S. Steinberg, S. Broder, I. Feuerstein, 1990, Annals of internal medicine.

Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.

D. Venzon, S. Broder, J. Karp, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.